Brief: HLS Therapeutics Announces CFO Departure
18/12/2023 11:33
Dec 18 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS ANNOUNCES CFO DEPARTURE
* HLS THERAPEUTICS INC: JOHN HANNA APPOINTED INTERIM CFO TO
REPLACE DEPARTING CFO TIM HENDRICKSON
* HLS THERAPEUTICS INC: HENDRICKSON WILL REMAIN IN HIS ROLE
UNTIL
JANUARY 26, 2024
Source text for Eikon: ID:nCNWDxBSya
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease